13024_2021_441_MOESM1_ESM.docx (19.59 kB)
Additional file 1 of Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
journal contribution
posted on 2021-03-20, 04:42 authored by Jillian H. Kluss, Melissa Conti Mazza, Yan Li, Claudia Manzoni, Patrick A. Lewis, Mark R. Cookson, Adamantios MamaisAdditional file 1 Table S1: Table of antibody summary. All antibodies used in this study are listed with catalog numbers, and working concentrations used. IgG concentrations are supplied in brackets.
Funding
Michael J. Fox Foundation for Parkinson's Research National Institute on Aging (NIA)
History
Usage metrics
Categories
Keywords
kinase inhibitionLRRK 2 autophosphorylationProteomic analysisprotein kinaseLRRK 2 inhibitiontrafficking pathwaysLRRK 2kinase LRRK 2kinase 2 genewashout conditionsLRRK 2 inhibitorpS 106 Rab 12brain tissuevivo PD modelendolysosomal systemRab substrates10 weeksin-diet administrationPreclinical modelingvivo AbstractRab GTPases phosphorylationLRRK 2 activityPD patientsproteomic analysesmitochondrial proteinspharmacodynamic responseMLi -2G 2019S LRRK 2 knock-in miceMLi -2 treatment
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC